Literature DB >> 31903817

Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer.

Jaber Emami1, Moloud Kazemi1, Farshid Hasanzadeh2, Mohsen Minaiyan3, Mina Mirian4, Afsaneh Lavasanifar5.   

Abstract

In this study, pH-triggered polymeric micelle comprising α-tocopherol (TOC) and heparin (HEP) was developed and loaded with docetaxel (DTX). The amphiphilic copolymer was synthesized by grafting TOC onto HEP backbone by a pH-cleavable bond. DTX-loaded micelles were characterized in terms of critical micelle concentration (CMC), particle size, zeta potential, entrapment efficiency (EE), pH-responsive behavior, and drug release. In vitro cytotoxicity of the micelles against breast cancer cells was investigated by MTT assay. The cellular uptake of coumarin-loaded micelles was also evaluated. Furthermore, the pharmacokinetics of DTX-loaded micelles was evaluated and compared with that of Taxotere®.HEP-CA-TOC copolymers showed low CMC values and high EE. At pH 7.4, the micelles remained stable in size and shape, whereas considerable changes in particle size and morphology were observed at pH 5.5. DTX-loaded micelles showed pH-dependent drug release profiles. Coumarin-loaded micelles showed higher cellular uptake than free coumarin. Therefore, the DTX-loaded micelles showed more toxicity against breast cancer cells than free DTX. A significant increase in T1/2 β, AUC0-∞ and MRT was observed in DTX-loaded micelle treated group as compared to the group treated with Taxotere®.The results suggest that the pH-sensitive HEP-modified micelles could be promising for enhanced intracellular drug delivery of DTX for cancer treatment.

Entities:  

Keywords:  Polymeric micelle; breast cancer; docetaxel; heparin; pH-sensitive; tocopherol

Mesh:

Substances:

Year:  2020        PMID: 31903817     DOI: 10.1080/10837450.2019.1711395

Source DB:  PubMed          Journal:  Pharm Dev Technol        ISSN: 1083-7450            Impact factor:   3.133


  5 in total

Review 1.  Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges.

Authors:  Vivek P Chavda; Aayushi B Patel; Kavya J Mistry; Suresh F Suthar; Zhuo-Xun Wu; Zhe-Sheng Chen; Kaijian Hou
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

Review 2.  Antioxidants for the Treatment of Breast Cancer: Are We There Yet?

Authors:  Carmen Griñan-Lison; Jose L Blaya-Cánovas; Araceli López-Tejada; Marta Ávalos-Moreno; Alba Navarro-Ocón; Francisca E Cara; Adrián González-González; Jose A Lorente; Juan A Marchal; Sergio Granados-Principal
Journal:  Antioxidants (Basel)       Date:  2021-01-31

Review 3.  Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules.

Authors:  Nipa Banik; Seong-Bin Yang; Tae-Bong Kang; Ji-Hong Lim; Jooho Park
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 5.923

Review 4.  Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy.

Authors:  Lekshmi Rethi; Chinmaya Mutalik; Dito Anurogo; Long-Sheng Lu; Hsiu-Yi Chu; Sibidou Yougbaré; Tsung-Rong Kuo; Tsai-Mu Cheng; Fu-Lun Chen
Journal:  Nanomaterials (Basel)       Date:  2022-08-26       Impact factor: 5.719

5.  Development of a RP-HPLC method for analysis of docetaxel in tumor-bearing mice plasma and tissues following injection of docetaxel-loaded pH responsive targeting polymeric micelles.

Authors:  Moloud Kazemi; Jaber Emami; Farshid Hasanzadeh; Mohsen Minaiyan; Mina Mirian; Afsaneh Lavasanifar
Journal:  Res Pharm Sci       Date:  2020-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.